PPHF 2012 National Diabetes Prevention Program Preventing Type 2 Diabetes Among People at High Risk financed solely by 2012 Prevention and Public Health Funds
Opportunity Identification: CDC RFA DP12 1212PPHF12
Opportunity summary
The funding mechanism was a cooperative agreement, which generally means recipients would not only receive funding but would also be expected to work in coordination with CDC, with substantial federal involvement typical of cooperative agreements. The activity category was health, and the listing referenced CFDA number 93.739, associated with PPHF chronic disease innovation grants funded exclusively through public prevention and health funds. The program did not require cost sharing or matching, reducing barriers for organizations that might not have additional funds to contribute alongside the federal award.
The opportunity anticipated making up to eight awards. Individual award amounts were structured within a defined range, with an award floor of $750,000 and an award ceiling of $2,000,000. This spread suggests CDC intended to support a small number of relatively well-resourced, high-impact projects capable of expanding program reach and building long-term infrastructure for diabetes prevention services rather than funding many small pilot initiatives.
Eligibility was broad and included nonprofit organizations, for-profit organizations, Indian/Native American tribal governments, and faith-based organizations. The announcement noted "Others" with a reference to additional eligibility language in the full text, indicating that more detailed or conditional eligibility criteria may have applied depending on organizational type, partnerships, or the nature of proposed activities. The diversity of eligible applicants aligns with the National DPP model, which often relies on cross-sector delivery systems and community-based access points to reach people at risk, including through employers, healthcare-adjacent entities, community organizations, and trusted local institutions.
Key dates show this was a time-limited 2012 opportunity. The posting date was June 22, 2012, with a closing deadline of July 31, 2012 (both the original and current closing date were the same), and an archive date of August 30, 2012. The creation date was listed as July 17, 2012, which is consistent with internal record timing that can occur after initial posting. Interested applicants during that period would have had a short application window, emphasizing the need for readiness and existing capacity to implement an expansion-focused prevention program quickly.
For applicant support and submission issues, the CDC provided a point of contact through CDC PGO TIMS, with a phone number (770-488-2700) for general submission inquiries and assistance accessing the full announcement electronically. Overall, the opportunity was designed to invest substantial prevention funding into organizations capable of expanding the National DPP and putting in place sustainable systems to reduce progression to type 2 diabetes among high-risk populations.
Frequently asked questions
What is the official title of this grant opportunity?
The official title is "PPHF 2012 National Diabetes Prevention Program: Preventing Type 2 Diabetes Among People at High Risk."
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is CDC RFA DP12-1212PPHF12.
Which federal agency released this funding opportunity?
This discretionary funding announcement was released by the Centers for Disease Control and Prevention (CDC).
What is the main purpose of this grant?
The overall purpose is to scale up (expand) and sustain the National Diabetes Prevention Program (National DPP), a national initiative designed to prevent or delay the onset of type 2 diabetes among people identified as being at high risk.
What program or initiative is this funding intended to support?
The funding is intended to support the National Diabetes Prevention Program (National DPP), focusing on expansion and sustainability rather than small, short-term pilots.
What type of funding mechanism is being used?
The funding mechanism is a cooperative agreement.
What does it mean that this is a cooperative agreement?
Based on the announcement summary, a cooperative agreement indicates that recipients would receive funding and also be expected to work in coordination with CDC, with substantial federal involvement typical of cooperative agreements.
How is this opportunity funded?
This opportunity was financed solely through the 2012 Prevention and Public Health Fund (PPHF).
Is this a discretionary grant?
Yes. The announcement is described as a discretionary federal funding opportunity.
What is the activity category for this opportunity?
The activity category is health.
What CFDA number is referenced for this opportunity?
The listing referenced CFDA number 93.739.
What does the referenced CFDA number relate to in this announcement?
CFDA 93.739 is described as being associated with PPHF chronic disease innovation grants funded exclusively through public prevention and health funds.
Is cost sharing or matching required?
No. The program did not require cost sharing or matching.
How many awards were expected to be made?
The opportunity anticipated making up to eight awards.
What is the minimum (floor) award amount?
The award floor is $750,000.
What is the maximum (ceiling) award amount?
The award ceiling is $2,000,000.
What does the award range suggest about the type of projects CDC wanted to fund?
The stated range suggests CDC intended to support a small number of relatively well-resourced, high-impact projects capable of expanding program reach and building long-term infrastructure for diabetes prevention services, rather than funding many small pilot initiatives.
Who was eligible to apply?
Eligibility was described as broad and included nonprofit organizations, for-profit organizations, Indian/Native American tribal governments, and faith-based organizations.
The eligibility section mentions "Others." What does that mean?
The announcement noted "Others" with a reference to additional eligibility language in the full text. This indicates more detailed and/or conditional eligibility criteria may have applied depending on organizational type, partnerships, or the nature of proposed activities.
When was the opportunity posted?
The posting date was June 22, 2012.
What was the application deadline?
The closing deadline was July 31, 2012. The original and current closing date were the same.
When was the opportunity archived?
The archive date was August 30, 2012.
What is the creation date listed for this opportunity?
The creation date was listed as July 17, 2012.
Does the timing indicate a short application window?
Yes. The posting and closing dates (June 22, 2012 to July 31, 2012) indicate a relatively short window, which suggests applicants would have needed readiness and capacity to implement an expansion-focused prevention program quickly.
Who should applicants contact for submission issues or access to the full announcement?
The CDC provided a point of contact through CDC PGO TIMS for general submission inquiries and assistance accessing the full announcement electronically.
What phone number was provided for help?
The phone number provided was 770-488-2700.
Is this opportunity still open?
No. The closing deadline was July 31, 2012, and the opportunity was archived on August 30, 2012.
What population is the National DPP expansion intended to serve under this funding?
This opportunity centers on preventing or delaying type 2 diabetes among people identified as being at high risk.
What general approach does the opportunity emphasize: starting new pilots or expanding existing efforts?
The emphasis is on scaling up (expanding) and sustaining the National DPP, indicating a focus on expansion and long-term sustainability.
Questions about this opportunity?
Contact USGrants.org for help with this listing or similar funding opportunities.
Contact USGrants.orgRelated funding listings
Applicants who have applied for this opportunity (CDC RFA DP12 1212PPHF12) also looked into and applied for these: